The global cancer biomarker market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. The major factor contributing to the growth of the market is the rising adoption of several R&D activities by the key market players along with FDA approvals across the globe For instance, in March 2021, Roche announced that the VENTANA ALK (D5F3) CDx Assay has been approved as a companion diagnostic by the US Food and Drug Administration. This assay test is the only one approved by the FDA as a companion diagnostic for LORBRENA, and it will aid in quickly identifying patients with this cancer biomarker so that they can receive more effective treatment.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cancer-biomarkers-market
Further, in December 2020, Thermo Fisher Scientific (US) received FDA approval NGS-based companion diagnostic for EGFR Exon20 insertion mutant non-small cell lung cancer tumor tissue. In July 2020, Thermo Fisher Scientific signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., as well as an application to the Ministry of Health, Labour, and Welfare (MHLW) to expand the use of the Oncomine Dx Target Test in Japan. This agreement focuses on accelerating the local biomarker testing of NSCLC patients in Japan who are candidates for entrectinib.
Apart from this, In April 2020, Qiagen N.V. (Netherlands) Launched therascreen BRAF test as a companion diagnostic to a BRAFTOVI (encorafenib) based regimen in metastatic colorectal cancer.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Biomarker Type
- By Cancer Type
- By Application
- By Profiling Technology
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Abbott Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck and Co., inc., Novartis AG, and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Healthcare BPO Market Report Segment
By Biomarker Type
- Genetic Biomarker
- Protein Biomarker
By Cancer Type
- Lung Cancer
- Prostate Cancer
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Other
By Application
- Drug Discovery and development
- Diagnosis
- Risk Assessment
- Prognostics
By Profiling Technology
- Omnic Technology
- Immunoassays
- Cytogenetics
- Bioinformatics
A full report of Cancer Biomarkers Market is available at: https://www.omrglobal.com/industry-reports/cancer-biomarkers-market
Cancer Biomarkers Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abcodia Ltd.
- Agendia N.V.
- Agilent Technologies, Inc.
- Astellas Pharma Inc.,
- Becton, Dickson, and Co.
- Biodesix, Inc.
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- Diazyme Laboratories Inc.
- Hologic, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
